openPR Logo
Press release

Global Drug Delivery Technologies Market to Reach USD 284.7 Bn by 2022

04-22-2016 08:40 AM CET | Health & Medicine

Press release from: credence research

Mounting Need for Better Patient Compliance to Drive the Global Drug Delivery Technologies Market to Reach USD 284.7 Bn by 2022

As reported by Credence Research, Inc. through their latest publication “Global Drug Delivery Technologies Market - Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016 - 2022,” the drug delivery technologies market was valued at USD 175.95 Bn in 2015, and is expected to reach USD 284.71 Bn by 2022, expanding at a CAGR of 6.9% from 2016 to 2022.

Browse the full report Global Drug Delivery Technologies Market - Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016 – 2022 report at http://www.credenceresearch.com/report/drug-delivery-technologies-market

Market Insights

Patent expiry of several major drugs, coupled with the expensive business of development of new chemical entity has posed as a prime concern for pharmaceutical manufacturers. Development of new chemical entity is often observed to be a more expensive affair than development of novel delivery technology. Hence, several pharmaceutical manufacturers have adopted new drug delivery technologies for their portfolio as an effective life cycle management strategy.

The global drug delivery devices market is studied for mode of administration and geography segmentations. Oral, pulmonary, transdermal, injectable, nasal, implantable, and ocular, buccal etc. cumulatively make the drug delivery technologies market. Among these, oral drug delivery is the largest segment, followed by pulmonary drug delivery in 2015 at a combined market share of over 65%.

For More Reports To similar category @ http://www.credenceresearch.com/industry/pharmaceuticals-market

Newer technologies through products such as orodispersible tablets, transdermal patches, pen injectors, powder inhalers and buccal tablets are among the most widely adopted products. Additionally, the demand for drug eluting implants is also on a continuous rise in the developed markets.

Implantable drug delivery devices find application in diabetes management, contraception, cardiology, pain management, pain management and others.
Geographically, North America is the largest regional market for drug delivery technologies. Well structured reimbursement policies, large scale adoption of latest technologies, high prevalence of chronic diseases and high level of awareness among both care givers and patients are the prime contributors to the growth of North America drug delivery technologies market. In terms of growth rate, Asia-Pacific and Latin America are the fastest developing markets for drug delivery technologies. Fast developing healthcare infrastructure, gradually rising awareness and improving healthcare expenditure supplement the growth of emerging markets.

Intense competition among drug manufacturers to manage product life cycles of blockbuster drugs, and rising trend of manufacturing outsourcing have made the drug delivery technologies market fragmented. Merck, 3M Company, Johnson and Johnson, Becton Diskinson and Company and others are some of the major players in the global drug delivery technologies market.

Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.

Name: Chris Smith (Global Sales Manager)
Address: 105 N 1st ST #429, SAN JOSE, CA 95103 US
E-mail: sales@credenceresearch.com
Ph: 1-800-361-8290
Web: http://www.credenceresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Drug Delivery Technologies Market to Reach USD 284.7 Bn by 2022 here

News-ID: 334776 • Views: 503

More Releases from credence research

Biodegradable Paper and Plastic Packaging Market is Growing and will Cross USD 2 …
Biodegradable Paper and Plastic Packaging Market Size, Driver and Forecast The biodegradable paper and plastics packaging market is growing at a fast pace across different regions. This is mainly due to the increasing awareness among consumers about the benefits of using biodegradable packaging. The growth of this market is also supported by government initiatives such as the Green India Program and Make in India. Credence Research has projected the biodegradable paper and
New Study On Liquid Metal Battery Market: Growing with Vast Opportunities
In 2020, the global Next Generation Liquid Metal Battery market produced a revenue of around USD 3,500 million and anticipated to grow at a CAGR of over 11.2% during the forecast period from 2021 to 2027 to reach around USD 6,700 million in 2027. Three liquid layers serve as electroactive components in the liquid metal battery. The development of a liquid metal battery is a novel approach to solving grid-scale electricity
Nanocrystal market to grow at a CAGR of over 16% during the forecast period
The nanocrystal market generates revenue of around USD 82.5 million in 2020, and is projected to grow at a CAGR of over 16% during the forecast period from 2021 to 2027 to reach USD 233.16 million in 2027. A crystalline particle is called a nanocrystal only if it is a particle with a dimension less than one thousand nanometers (nanometer). With its proven results, nanocrystals are broadly used in a variety
Oil Spill Management Market- COVID19 Impact Analysis, Growth, Trends and Forecas …
The global oil spill management market was US$ 132.6 billion in 2018, with CAGR expected to grow by 3.1 per cent from 2019 to 2027, reaching US$ 174.5 billion in 2027. Market Insights "Rising oil spilling accidents demand oil spill management" Oil spilling is a major environmental concern in the world. According to the EPA, almost 14,000 oil spills are reported annually in the United States alone. The major impact is on marine

All 5 Releases


More Releases for Drug

Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June. The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug